COOPER COMPANIES Business Summary

The Cooper Companies, Inc. (COO) is a global medical device leader that generates revenue through the development, manufacture, and sale of specialty healthcare products across two primary segments: CooperVision and CooperSurgical. CooperVision, accounting for approximately two-thirds of total revenue, specializes in the soft contact lens market with a focus on high-margin spherical, multifocal, and toric lenses, as well as the MiSight myopia management system. CooperSurgical focuses on women’s health, fertility, and diagnostics, providing a comprehensive suite of IVF consumables, medical devices, and the hormone-free Paragard IUD. For fiscal year 2025, the company reported record revenues of $4.1 billion and has issued fiscal 2026 guidance projecting growth to approximately $4.3 billion. In the competitive landscape, CooperVision maintains a top-three global market position alongside Alcon, Johnson & Johnson Vision, and Bausch + Lomb, distinguishing itself through a dominant share in the specialty lens and myopia control categories, while CooperSurgical competes with firms like Vitrolife and Hamilton Thorne in the fertility sector. Leadership is currently spearheaded by President and CEO Albert G. White III, who assumed the role in 2018 after serving as the company’s CFO and Chief Strategy Officer. The executive team includes Brian Andrews as EVP and CFO, and Daniel G. McBride, who serves as EVP, COO, and General Counsel. As of January 2, 2026, Colleen Jay, a former Global Division President at Procter & Gamble with over three decades of operational experience, succeeded long-time leader Robert Weiss as Chair of the Board. The board recently expanded to include Walter M. Rosebrough Jr., the former CEO of STERIS, following a cooperation agreement with activist investor Browning West, LP. This leadership transition coincides with a formal strategic review initiated in late 2025 aimed at optimizing the company’s corporate structure and capital allocation to enhance long-term shareholder value.